Abstract
A stability-indicating reversed-phase HPLC method for assay of milbemycin oxime (MO) and estimation of its related compounds has been developed and validated as per VICH and ICH method validation guidelines. The stability-indicating capability of this method has been demonstrated by adequate separation of all process-related impurities including all potential degradation products of milbemycin oxime (MO) that were generated using stress degradation conditions that are prescribed in ICH guideline. The stability-indicating capabilities of this method were further challenged by analyzing aged stability samples of MO active pharmaceutical ingredient (API). Chromatographic separation of MO and its related compounds was achieved using an isocratic elution at a flow rate of 0.5 mL/min on a Supelco Ascentis Express C18 column (100 mm × 3.0 mm, 2.7 µm particle size, 90 Å pore size) maintained at 50 °C. The isocratic mobile phase was composed of 30% v/v of 0.05% phosphoric acid in aqueous solution and 70% v/v of a mixture of methanol and acetonitrile (6:4, v/v). UV detection at 244 nm was employed to monitor the analytes.












Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
The Nobel Prize in Physiology or Medicine 2015, Nobel Lectures: (1) Youyou Tu, Discovery of Artemisinin—A Gift from Traditional Chinese Medicine to the World, (2) William C. Campbell, Ivermectin, A Reflection on Simplicity, (3) Satoshi Ōmura, A Splendid Gift from the Earth, The Origins and Impact of Avermectin
Davies HG, Green RH (1991) Chem Soc Rev 20:211–269
Davies HG, Green RH (1991) Chem Soc Rev 20:271–339
Davies HG, Green RH (1986) Nat Prod Rep 3:87–121
Jung M, Saito A, Buescher G, Maurer M, Graf JF (2002). In: Vercruysse J, Rew RS (eds) Macrocyclic lactones in antiparasitic therapy. CABI Publishing, Oxon, pp 51–74
Martin RJ (1997) Vet J 154:11–34
Wolstenholme AJ (2012) J Bio Chem 287(48):40232–40238
Hibbs RE, Gouaux E (2011) Nature 474:54–60
Milbemycin oxime monograph (2010) In-process revision. Pharmacop Forum 36:417
(2013) Milbemycin oxime for veterinary use, Pharmeuropa, 25.1, (Reference: PA/PH/Exp. 7/T (09) 21 ANP), 137–142
Danaher M, Howells LC, Crooks SRH, Cerkvenik-Flajs V, O’Keeffe M (2006) J Chromatogr B 844:175–203
Li J, Xu Q, Xiang W, Liu Y, Qu M, Zhang Y, Yu X (2010) Faming Zhuanli Shenqing 1:101915818
Xu Q, Shen Z, Guo S, Li F, Li J, Wang Y (2014) J Chromatogr Sci 52(9):999–1004
Xiao K, Xiong Y, Liu F, Rustum AM (2007) J Chromatogr A 1163:145–156
Xiao K, Chien D, Markovich R, Rustum AM (2007) J Chromatogr A 1157:207–216
Lu J, Wei YC, Rustum AM (2010) J Chromatogr A 1217:6932–6941
ICH Q2(R1) (2005) Validation of Analytical Procedures: text and methodology, November 2005, The international council on Harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH)
VICH GL1 (1998) Validation of analytical procedures: definition and terminology, October 1998, The international cooperation on Harmonisation of technical requirements for registration of veterinary medicinal products (VICH)
VICH GL2 (1998) Validation of analytical procedures: methodology, October 1998, The international cooperation on harmonisation of technical requirements for registration of veterinary medicinal products (VICH)
Padivitage NLT, Armstrong DW (2011) J Sep Sci 34:1636–1647
Cole LA, Dorsey JG (1992) Anal Chem 64:1317–1323
Cole LA, Dorsey JG (1992) Anal Chem 64:1324–1327
Urban J, Jandera P, Kučerová Z, Straten MA, Claessens HA (2007) J Chromatogr A 1167:63–75
Jandera P, Krupczyńska K, Vyňuchalová K, Buszewski B (2010) J Chromatogr A 1217:6052–6060
Acknowledgements
The authors would like to thank BIAH and all the analytical scientists in Global Pharmaceutical Technical Support (GPTS) of BIAH at North Brunswick, New Jersey (R&D site) for their support of this study.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
Not applicable.
Consent for Publication
The authors’ affiliated company, Boehringer Ingelheim Animal Health approved the submission of this manuscript.
Disclaimer
This document is provided for scientific purpose only. Any reference to a brand or trademark herein is for informational purpose only and is not intended for a commercial purpose or to dilute the rights of the respective owner(s) of the brand(s) or trademark(s).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Huang, J., He, J. & Rustum, A.M. Development and Validation of a Stability-Indicating HPLC Method for Assay of Milbemycin Oxime and Estimation of Its Related Compounds. Chromatographia 84, 483–498 (2021). https://doi.org/10.1007/s10337-021-04028-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10337-021-04028-9


